Whittemore R., Hobbins J.C., Engle M.M. Pregnancy and its outcome with and without surgical treatment of congenital heart disease. Am J Cardiol.1982;50:641-648.
Kuc zkowski K.M. labor analgesia for the parturient with cardiac disease: what does an obstetrician need to know? Acta Obstet Gynecol Scand.2004;83(3):223-330.
Malhotra M., Sharma J.B., Tripathiir Arora P. Maternal and fetal outcome in valvular heart disease. Int J Gynaecol Obstet.2004;84(1):11-6.
Braunwald E. Heart disease, a textbook of cardio-vascular medicine. Vol(1), 6th Edition, W.B. Saunders, U.S.A.2001;pp:2172-2186.
Vitale N., Defeo M., Cotrufo M. Anticoagulation for prosthetic heart valve during pregnancy: The impor-tance of warfarin daily dose. Eur J Cardio Thorac Surg. 2002;22:656-657.
Hou J.W. Fetal warfarin syndrome. Chang Gung Med J. 2004;27(9):691-5.
Bloomfield P. Choice of heart valve prosthesis. Heart. 2002;87:583-589.
Regenstein A .Risk of warfarin during pregnancy with mechanical valve prosthese. Obstet Gynecol.2002;99 (1):35-40.
Cunningham F., Macdonald P., Gant N., Leveno K., Gilftap L., et al. Williams Obstetrics. 21th Edition, Prentice Hall.2001; pp:1366.
Abdallah M.Y., Din Mostafa E.E. Contraception after heart surgery. Contraception.1992;45(1):73-80.
Tong E. An overview of artificial heart valve replace-ment infants and children. J Cardiovasc Nurs.1992;6 (3):30-43.
Qeelani M.A., Singh S., Verma A., Nagesh A., Beti-geri V., Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann.2005;13(1):30-3.
Ageno W., Crotti S., Turpie A.G. The safety anthrom-botic therapy during pregmancy.Expert Opin Drug Saf. 2004;3(2):113-8.
Mendelson M.A. Gynecologic and obstetric issues in the adolescent with heart disease. Adolesc Med.2001; 12(1):163-74.
Kleinman R.L. Family planning hand book for doctors IPPF Medical publications. 6th Edition.1988;pp:113.